Project Grant R01EY039033
Award Date 8/1/26
Completion Date 7/31/31
Dollars Obligated $1M
Funding Federal Agency
Awarding Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Boston, MA 02114, USA
Similar Awards
- The National Institutes of Health Office of the Director awarded New York University School of Medicine $100,001 under the Vision Research program (CFDA 93.867) on August 1, 2026, to develop and evaluate BARBER-CLIP, a community-engaged, barbershop-based tele-screening model for diabetic retinopathy. The recipient will train community health workers to screen men for diabetic retinopathy in barbershops and refer positive cases to ophthalmologic care, building on a successful...
- The National Eye Institute, part of the National Institutes of Health, awarded the University of New Mexico Health Sciences Center $350,000 on September 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to investigate neutrophil extracellular traps and chemokine signaling in blood-retinal barrier disruption in diabetic retinopathy. The funded research targets mechanisms underlying diabetic retinopathy, the leading cause of vision loss in middle-aged adults....
- The National Eye Institute, part of the Department of Health and Human Services National Institutes of Health, awarded $439,174 to the Regents of the University of Minnesota on September 1, 2026, under the Vision Research program (CFDA 93.867) to conduct the first study quantifying how autonomous artificial intelligence diagnostic systems expand access to diabetic retinopathy screening and treatment. The project will use 100% of Medicare claims data to identify adoption of FDA-approved...
- The National Eye Institute awarded The Schepens Eye Research Institute $858,394 on August 1, 2026, under the Vision Research program (CFDA 93.867) to develop multimodal foundation models for eye disease screening and prognosis. The research develops a vision-language foundation model trained on pairs of retinal images and clinical notes to enable downstream supervised models for detection and progression prediction of age-related macular degeneration, diabetic retinopathy, and glaucoma. The...
- The National Eye Institute awarded $753,787 to The General Hospital Corporation (doing business as Massachusetts General Hospital) on August 1, 2026, under the Vision Research program (CFDA 93.867) to develop low-cost ultra-widefield retinal optical coherence tomography (OCT) technology based on photonic-electronic integration. The project addresses cost barriers that limit clinical availability of OCT instrumentation used to detect and monitor diabetic retinopathy, age-related macular...
- The National Institute for Minority Health and Health Disparities awarded The Regents of the University of Colorado (University of Colorado-Denver) $330,001 on July 1, 2026, under the Vision Research program (CFDA 93.867) to develop a multidisciplinary telemedicine model for chronic pediatric uveitis care. The telemedicine model will deliver remote diagnostic and management services from pediatric ophthalmologists, uveitis specialists, and pediatric rheumatologists to children with chronic...
- The National Eye Institute awarded Massachusetts Eye and Ear Infirmary $467,277 on July 1, 2026, under the Vision Research program (CFDA 93.867) to develop and validate a clinical neuropsychological assessment battery combined with mobile eye tracking to characterize the visuoperceptual profile of cerebral visual impairment. The testing battery comprises five standardized neuropsychological assessments focused on evaluating visual scanning, planning, processing speed, and visuomotor...
- The National Eye Institute awarded Pennsylvania State University's Penn State Milton S. Hershey Medical Center $430,650 on June 1, 2026, under the Vision Research program (CFDA 93.867) to conduct exploratory and developmental research on the renal-retinal axis in diabetic retinopathy. The research addresses an unmet clinical need for preventative therapeutic strategies targeting the underlying molecular events that cause diabetic retinopathy in its early stages. Current standard-of-care...
- The National Eye Institute awarded the University of Utah $759,312 on July 1, 2026, under the Vision Research program (CFDA 93.867) to conduct the Community Eye Connect (CEC) Trial, a multi-level health informatics intervention designed to increase follow-up rates for patients with positive diabetic retinopathy screening identified through telemedicine. The trial tests a theoretically-driven, two-level intervention targeting clinic processes and patient engagement to address a documented gap...
- The National Eye Institute awarded The General Hospital Corporation (Massachusetts General Hospital) $453,750 on September 1, 2026, under the Vision Research program (CFDA 93.867) to establish a stratified risk profile for cerebral visual impairment in infants. The project will utilize an existing clinical dataset to identify infant, maternal, and neurologic risk factors associated with cerebral visual impairment (CVI) diagnosis. The research will examine records from 400 patients with CVI and...